EX-23.1 2 tm2116867d9_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the inclusion in this Amendment No. 1 to Registration Statement (No. 333-262766) of MEDIROM Healthcare Technologies Inc. on Form F-1 of our report dated May 17, 2021 with respect to our audits of the consolidated financial statements of MEDIROM Healthcare Technologies Inc. as of, and for the years ended, December 31, 2020 and 2019, which includes an emphasis of matter paragraph as to significant uncertainty related to the future outcome from the outbreak associated with the COVID-19 pandemic, appearing in the Prospectus, which is part of the Amendment No. 1 to Registration Statement. We also consent to the reference to our firm under the heading “Experts” in such prospectus.

 

Our report refers to the adoption of new method of accounting for revenues and certain contract costs as of January 1, 2020.

 

/s/ BAKER TILLY US, LLP

Irvine, California

February 24, 2022

 

Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. © 2020 Baker Tilly US, LLP